Impetus Digital

DECEMBER 23, 2024

Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. This transformative series will showcase the 2025 Pharma Toolkit for Virtual Medical Education, revealing groundbreaking virtual tools and strategies set to revolutionize how we engage and educate HCPs, patients, and teams.

Education 102

Education Medical Pharma Training 102

MedCity News

DECEMBER 22, 2024

Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the companys Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach. The post Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM appeared first on MedCity News.

Medical 119

Medical 119

Pharmaceutical Technology

DECEMBER 24, 2024

The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.

FDA 105

FDA Marketing 105

pharmaphorum

DECEMBER 27, 2024

WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum

91

91

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmaTech

DECEMBER 25, 2024

Results from a Phase IIb study missed the primary endpoint by failing to achieve statistical significance.

69

69

MedCity News

DECEMBER 26, 2024

Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics. The post The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender appeared first on MedCity News.

Pharmaceutical 106

Pharmaceutical Biopharma Pharma 106

pharmaphorum

DECEMBER 24, 2024

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.

Marketing 91

Marketing 91

PharmaTech

DECEMBER 26, 2024

The launch of Roche's cobas mass spectrometry solution will bring fully automated mass spec analysis to the clinical lab.

64

64

MedCity News

DECEMBER 23, 2024

Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare leaders. The post Healthcare Leaders Slam Exclusion of Key Healthcare Provisions in Spending Package appeared first on MedCity News.

Healthcare 112

Healthcare Healthcare Government 112

Pharmaceutical Technology

DECEMBER 24, 2024

XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.

64

64

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

DECEMBER 22, 2024

Novo Nordisk data on obesity candidate CagriSema falls short of expectations, wiping around $94 billion off its market valuation.

Marketing 83

Marketing 83

PharmaTech

DECEMBER 25, 2024

Revised guidelines published by EMA and HMA update the rules on identification of commercially confidential information and personal data used in marketing authorization applications.

Medicine 64

Medicine Marketing 64

MedCity News

DECEMBER 22, 2024

As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond. The post 2025 and Beyond: Key Trends to Watch in Pharmacy appeared first on MedCity News.

Prescription 97

Prescription Pharmaceutical Biopharma Medical 97

Pharmaceutical Technology

DECEMBER 23, 2024

Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.

FDA 64

FDA 64

Advertisement

pharmaphorum

DECEMBER 24, 2024

The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.

FDA 74

FDA 74

PharmaTech

DECEMBER 23, 2024

The company is voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1 mg/mL) 30 mL vials due to misleading labeling and its status as an unapproved drug.

64

64

MedCity News

DECEMBER 27, 2024

Fidelity Management & Research Company and Dexcom participated in URAs $200 million Series D round. The post URA Snags $200M, Hits $5.2B Valuation appeared first on MedCity News.

Management 88

Management 88

Pharmacy Times

DECEMBER 23, 2024

The approval of the generic to liraglutide injection, currently in shortage, could help increase patient access to the type 2 diabetes treatment.

Patients 61

Patients FDA 61

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

pharmaphorum

DECEMBER 22, 2024

Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome

FDA 75

FDA Pharma 75

PharmaTech

DECEMBER 23, 2024

Pharmaceutical Technology chats with Roger Viney from ICE Pharma about bile acids in detail, including how they are useful in helping to improve drug solubility and absorption.

Pharma 64

Pharma Pharmaceutical 64

MedCity News

DECEMBER 23, 2024

Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 FDA approval in plaque psoriasis, now has positive data from two pivotal tests in psoriatic arthritis. Bristol Myers Squibb is trying to add new indications for the drug and stay ahead of competitors including Takeda Pharmaceutical. The post Bristol Myers Squibbs Sotyktu Meets Goals in Two Pivotal Psoriatic Arthritis Studies appeared first on MedCity News.

FDA 82

FDA Pharmaceutical Marketing Biopharma 82

Pharmacy Times

DECEMBER 24, 2024

The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.

Patients 59

Patients 59

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

DECEMBER 24, 2024

AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.

Marketing 72

Marketing 72

PharmaTech

DECEMBER 26, 2024

Challenges that can prevent sponsors realizing the full potential of managed access programs can be overcome by embracing a just-in-time manufacturing strategy.

Manufacturing 59

Manufacturing Management 59

MedCity News

DECEMBER 22, 2024

Zepbounds clinical tests in obstructive sleep apnea showed improvement in breathing disruptions that were accompanied by reductions in body weight. The new approval gives the Eli Lilly medicine the opportunity to become a blockbuster seller in yet another indication. The post Eli Lillys Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea appeared first on MedCity News.

FDA 74

FDA Medicine Biopharma Pharma 74

Pharmaceutical Technology

DECEMBER 24, 2024

This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.

59

59

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

pharmaphorum

DECEMBER 24, 2024

AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in the class to be approved in the EU for a form of early-stage lung cancer.

70

70

Pharmacy Times

DECEMBER 27, 2024

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

Safety 52

Safety 52

MedCity News

DECEMBER 23, 2024

From a marketing perspective, there are three significant trends to watch in 2025 strategic brand partnerships, AI-driven healthcare information delivery, and the fundamental shift in social media engagement paradigms. The post Healthcare Marketing: Key Trends Shaping 2025 appeared first on MedCity News.

Healthcare 79

Healthcare Healthcare Marketing Media 79

Pharmaceutical Technology

DECEMBER 24, 2024

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive agreement for RPT904 to treat various allergic conditions.

Pharmaceutical 59

Pharmaceutical 59

Advertisement

Distribution